At the center of this exhibition are designs for high volume and high viscosity formulations.
Menu
Combining internal knowledge and experience with active partnerships, SHL has launched a number of initiatives in the digital space for drug delivery systems.
SHL Group has announced that it will be holding a webinar discussing…
The rapid growth of biologics and biosimilars has significantly increased the demand for self-injection devices for the treatment of chronic indications.
An article examining SHL’s patient-centric approach to industrial designs was published in the May 2017 issue of OnDrugDelivery Magazine.
The growing demand for treatments using biological drugs has created a challenge for injectable devices to deliver next-generation, high viscosity formulations all the while putting patient comfort and usability first.
SHL will also show the highly-anticipated ENYA Platform, a smart add-on injection tracking offering developed in partnership with Innovation Zed Ltd.
Visit SHL at the Taipei Shangri-La’s Far Eastern Plaza Hotel to learn more about our devices, packaging solutions and innovative offers.
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow.
